While the clinical dementia findings did not reach statistical significance, they were the first to provide a hint that early ...

Crizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.

They abandoned their relationships, jobs, and lives for a total devotion to God and their fellow sisters. What can we learn ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

By 2050, over half of the adults and one third of the youth may be obese. Experts have called for urgent action to prevent ...

The World Health Organization (WHO) has identified severe heavy bleeding known as haemorrhage, and hypertensive disorders ...

There are several merchants of death prowling the nooks and crannies of Nigeria. They range from bandits, kidnappers, ritual ...

Konya as a Turkish city with a history stretching back to the early Seljuk era has a wide variety of striking minaret styles, ...

Ken Kato, MD, discussed the FDA approval of tislelizumab for the first-line treatment of esophageal squamous cell carcinoma.